Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 107 for breast cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development

    Jacksonville, FL

  2. A Study to Establish a Living Breast Organoid Biobank for Translational Research

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Registry For The Collection And Maintenance Of Biological Specimens For Breast Cancer Research

    Rochester, MN

  4. Improving Management of Breast Biopsy With Genetic Testing

    Jacksonville, FL

  5. Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy

    Jacksonville, FL

  6. Immune Archetecture of Stage 4 Triple-Negative Breast Cancer

    Jacksonville, FL

  7. A Study to Evaluate Screening Contrast Enhanced Digital Mammogram (CEDM) in Study Participants at Intermediate Breast Cancer Risk and Polygenic Risk Score (PRS) Results

    Rochester, MN

  8. Management of Locoregional Recurrent Breast Cancer

    Rochester, MN

  9. GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia

    Rochester, MN, Albert Lea, MN, Mankato, MN

.

Mayo Clinic Footer